Tutorials
Janux Therapeutics Inc logo

Janux Therapeutics Inc

$ 13.84 +0.18 (+1.32%) 10:08 PM EST
P/E:
At Loss
P/B:
1.61
Market Cap:
$ 576.15M
Enterprise V:
$ 215.10M
Volume:
53.56K
Avg Vol (2M):
90.19K
Volume:
53.56K
Market Cap $:
576.15M
PE Ratio:
At Loss
Avg Vol (2-Month):
90.19K
Enterprise Value $:
215.10M
PB Ratio:
1.61
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download Tutorials

Business Description

Janux Therapeutics Inc
NAICS : 325412 SIC : 2834
11099 N. Torrey Pines Road, Suite 290, La Jolla, CA, USA, 92037
Description
Janux Therapeutics Inc is an innovative biopharmaceutical company developing next-generation therapeutics based on proprietary tumor activated T Cell Engager platform technology to better treat patients suffering from cancer.
Name Current Vs Industry Vs History
Cash-To-Debt 2360.78
Equity-to-Asset 0.97
Interest Coverage No Debt
Piotroski F-Score N/A/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 28.16
Distress
Grey
Safe
Beneish M-Score 7.3
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 62.26
9-Day RSI 53.89
14-Day RSI 52.72
6-1 Month Momentum % -18.54
12-1 Month Momentum % -64.02

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 29.14
Quick Ratio 29.14
Cash Ratio 28.86
Days Sales Outstanding 219.68

Dividend & Buy Back

Name Current Vs Industry Vs History

Financials (Next Earnings Date:2022-08-10 Est.)

JANX's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:JANX

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 4.846
EPS (TTM) ($) -1.53
Beta 0
Volatility % 67.92
14-Day RSI 52.72
14-Day ATR ($) 1.393003
20-Day SMA ($) 14.184
12-1 Month Momentum % -64.02
52-Week Range ($) 9.39 - 35.8
Shares Outstanding (Mil) 41.63

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 9999
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Janux Therapeutics Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More